Bayer applies for EU approval of menopause drug elinzanetant

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.

Oct 16, 2024 - 04:00

Bayer applies for EU approval of menopause drug elinzanetant

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.

Read the original article

Tags:

Previous Article

Lilly touts Omvoh’s superiority over J&J’s Stelara in Crohn’s

Transgene’s stock drops after Phase II cancer jab trial misses primary endpoint

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Who’s in charge of the White House Covid response after the emergency ends?

Who’s in charge of the White House Covid response after...

May 9, 2023

UK bans xylazine and 21 other substances to fight drug abuse

UK bans xylazine and 21 other substances to fight drug ...

Sep 6, 2024

Opinion: Defunding liberal arts is dangerous for health care

Opinion: Defunding liberal arts is dangerous for health...

Jan 24, 2024